Mesoblast Limited

MESO ·Healthcare, Drug Manufacturers - General, Australia
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2019

Total Assets: $652.1M

Liabilities Breakdown FY2019

Total Liabilities: $171.1M